LY6K promotes glioblastoma tumorigenicity via CAV-1-mediated ERK1/2 signaling enhancement.
Sastry NG, Wan X, Huang T, Alvarez AA, Pangeni RP, Song X, James CD, Horbinski CM, Brennan CW, Nakano I, Hu B, Cheng SY.
Sastry NG, et al. Among authors: cheng sy.
Neuro Oncol. 2020 Sep 29;22(9):1315-1326. doi: 10.1093/neuonc/noaa032.
Neuro Oncol. 2020.
PMID: 32055849
Free PMC article.